|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/00 | |
| C07K 16/10 | |||
| C07K 16/28 | |||
| C07K 16/40 | |||
| A61K 47/68 | |||
| A61P 31/00 |
| (11) | Number of the document | 3142700 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15793257.5 |
| Date of filing the European patent application | 2015-05-15 | |
| (97) | Date of publication of the European application | 2017-03-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/030964 |
| Date | 2015-05-15 |
| (87) | Number | WO 2015/175874 |
| Date | 2015-11-19 |
| (30) | Number | Date | Country code |
| 201461994379 P | 2014-05-16 | US |
| (72) |
TSUI, Ping, US
BORROK, Martin, US
DALL`ACQUA, William, US
WU, Yanli, US
BEYAZ-KAVUNCU, Nurten, US
|
| (73) |
Medimmune, LLC,
One Medimmune Way, Gaithersburg, Maryland 20878,
US
|
| (54) | MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |
| MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES |